What question did this study set out to answer?

This study aims to evaluate the efficacy and safety of efgartigimod in treating juvenile myasthenia gravis (JMG).

March 10, 2026Muscle & Nerve0 citations

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study

JLJing LinTongji Hospital GQGuoyan QiFirst Hospital of Shijiazhuang SLSusan LuoHuashan Hospital

Key Points

This study aims to evaluate the efficacy and safety of efgartigimod in treating juvenile myasthenia gravis (JMG).
Retrospective analysis across multiple centers in China
Assessment of efficacy and safety profiles of efgartigimod
Inclusion of pediatric patients diagnosed with JMG
Efgartigimod demonstrated favorable efficacy in treating JMG
The safety profile was also found to be acceptable
Further studies are required to solidify these findings in the pediatric demographic

Abstract

Our study suggests efgartigimod is an effective therapeutic option for JMG, with favorable efficacy and safety profiles. Further studies are necessary to validate the efficacy and safety of efgartigimod in the pediatric population.

AIに質問

Bookmark

View Full Paper